Cleveland BioLabs
CBLI
#9780
Rank
โ‚น4.42 B
Marketcap
โ‚น286.12
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: โ‚น4.42 Billion

As of January 2026 Cleveland BioLabs has a market cap of โ‚น4.42 Billion. This makes Cleveland BioLabs the world's 9780th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022โ‚น4.06 B11.18%
2021โ‚น3.65 B11.21%
2020โ‚น3.28 B577.12%
2019โ‚น0.48 B-39.21%
2018โ‚น0.79 B-72.37%
2017โ‚น2.88 B172.4%
2016โ‚น1.06 B-58.39%
2015โ‚น2.54 B146.8%
2014โ‚น1.03 B-68.38%
2013โ‚น3.26 B0.26%
2012โ‚น3.25 B-39.37%
2011โ‚น5.37 B-42.66%
2010โ‚น9.36 B201.94%
2009โ‚น3.10 B121.3%
2008โ‚น1.40 B-68.53%
2007โ‚น4.45 B68.75%
2006โ‚น2.63 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
โ‚น1.88 B-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น95.28 B 2,051.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น15.821 T 357,152.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น24.561 T 554,482.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
โ‚น10.247 T 231,280.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.408 T 234,928.99%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚น9.191 T 207,449.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
โ‚น1.24 B-71.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น87.465 T 1,974,847.96%๐Ÿ‡บ๐Ÿ‡ธ USA